Risk Stratification in PAH: What Do the Latest Data Suggest?

Registry Studies

2015 ESC/ERS Guidelines Risk Assessment in PAH

French PH Registry Low-Risk Criteria

French PH Registry Baseline Characteristics

French PH Registry Number of Low-Risk Criteria Achieved and Survival

French PH Registry Number of Noninvasive Low-Risk Criteria Achieved and Survival

French PH Registry Take-Home Message

COMPERA Registry Risk Stratification

COMPERA Registry Baseline Characteristics

COMPERA Registry 1-Year Mortality

COMPERA Registry Take-Home Messages

SPAHR Risk Stratification

SPAHR 5-Year Survival

SPAHR Change in Risk Group at Follow-Up and 5-Year Survival

SPAHR Take-Home Messages

REVEAL Registry PAH Risk Score

REVEAL Registry Updated PAH Risk Score

Need for Early Diagnosis and Intensification of Disease Management

Monotherapy Is Frequently Inadequate

PAH Population Is Heterogeneous

French PH Registry Early Combination Treatment Leads to Better Long-Term Survival

Role of PAH Centers

Multidisciplinary Approach to PAH Management

Place of Lung Transplantation in PAH Management

Summary

Abbreviations

Abbreviations (cont)